The industry is buzzing about AI agents that could automate this work. But here’s what most companies miss: You can’t hand ...

The discussion, featuring Shanghvi alongside Aurobindo Pharma whole-time director Madan Mohan Reddy, Lupin managing director Nilesh Gupta and Zydus Lifesciences managing director Sharvil Patel, ...

Jay Bregman, CEO and co-founder of Andel, discusses how pharmaceutical companies and digital health platforms may need to rethink commercialization strategies, shifting away from costly mass-market ...

The healthcare editorial teams discusses the key trends and growth drivers in companies' recent 2025 financial results.

Tarsus Pharmaceuticals remains a Strong Buy, driven by Xdemvy's robust growth and management's $2B+ peak sales target. Click ...

Clawbacks, discontinued therapies, delays, lay-offs and disinvestment have created a concerning pharma business environment ...

Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...

Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House ...

Some of the conservative groups publicly opposing the Trump administration’s effort to force down drug prices are bankrolled by PhRMA, a trade organization with a vested interest in undoing the ...

We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on HalfBakedInnovations’s Substack by Biotech Distilled. In ...